High levels of CX3CL1, a pro-inflammatory molecule, in the lung tissue and blood are linked with pulmonary dysfunction in scleroderma (SSc) patients,…
Articles by Patricia Inácio, PhD
As people age they accumulate a subset of more pro-inflammatory monocytes, a type of immune cell, that may ultimately contribute…
Emerald Health’s lead cannabinoid-derived investigational therapy, EHP-101, shows promise as a possible oral treatment for scleroderma, a…
Autoreactive antibodies, or autoantibodies, were detected in the blood of patients with scleroderma (also called systemic sclerosis, or SSc)…
Inhalation of dust particles containing silica is linked to a higher prevalence of systemic sclerosis (SSc), namely the diffuse…
Light therapy delivered locally using a lamp that emits infrared, red and ultraviolet light reduced by 83 percent the burden…
A protein called BAFF, or B-cell activating factor, was found to drive skin and lung fibrosis in systemic scleroderma…
A lower score on the six-minute walk test (6MWT) correlates with disease severity and mortality in patients with…
High levels of a protein called KL-6, produced by lung cells and secreted into the blood, can predict early signs…
Levels of certain important signaling molecules called cytokines are associated with different clinical manifestations in patients with scleroderma, a…